Skip to content

Depression: all studies

Page 132 of 1,034: studies 1,311 to 1,320 of 10,336, newest first. Back to the depression overview

Research

Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression

Nature Mental Health August 5, 2024 Gustavo Deco, Yonatan Sanz Perl, Samuel G B Johnson et al. 39 citations

Abstract Effective interventions for neuropsychiatric disorders may work by rebalancing the brain’s functional hierarchical organization. Here we directly investigated the effects of two different serotonergic pharmacological interventions on functional brain hierarchy in major depressive disorder in a two-arm double-blind phase II randomized controlled trial comparing psilocybin therapy (22...

Novel treatments of depression: bridging the gap in current therapeutic approaches

Exploration of Neuroscience August 5, 2024 Amit Jagtiani 6 citations

Depression poses a significant global health burden, yet current therapeutic approaches focusing on monoaminergic neurotransmission often fall short of achieving full remission and managing acute episodes effectively. This article explores novel treatment avenues beyond conventional monoaminergic approaches, focusing on emerging strategies targeting glutamatergic modulation,...

DOI: 10.37349/en.2024.00049 (opens in new tab) Full text (opens in new tab) Psychedelic-assisted psychotherapy Glutamatergic modulation Brain stimulation Anti-inflammatory agents +9

Intervention Treatment for Anxiety and Depression-Induced Emotional Disorders in College Students: Mindfulness-Based Stress Reduction

Journal of Engineering and Science in Medical Diagnostics and Therapy August 1, 2024 Lili Zhang

Abstract The objective of this study was to investigate the effects of mindfulness-based stress reduction (MBSR) on relieving symptoms of emotional disorders caused by anxiety and depression in college students. Fifty college students with generalized anxiety disorder 7-item (GAD-7) scale scores >7 and self-rating depression scale (SDS) scores ≥50 were randomly divided into a blank group and an...

Low dose of esketamine after childbirth helps mothers at risk of depression

The Brown University Psychopharmacology Update August 1, 2024

Women with prenatal depressive symptoms who received a single low dose of esketamine shortly after childbirth showed a substantially lower incidence of a major depressive episode at 42 days postpartum than women receiving placebo, a new study has found. Neuropsychiatric adverse events occurred more frequently in the esketamine group, but no severe adverse events were reported.

A virtuous cycle between meaning in daily life and state mindfulness as well as the unique role of depression among young adults: A diary study.

Applied Psychology: Health and Well-Being August 1, 2024 Yangyu Lian, Wenrui Zhang, Ting He et al. 1 citation

The positive association between meaning in life (MIL) and mindfulness has been supported; however, previous research has been limited to the trait level. To explore the dynamics of mindfulness and MIL in the state level, the present study used the experience sampling method (ESM) and conducted a dynamic structural equation model (DSEM). In addition, we examined the moderation of baseline...

Golden steps: A nursing approach for vitality, agility, and rumination in geriatric clients with depressive disorders through mindful walking.

Archives of Psychiatric Nursing August 1, 2024 Mona Metwally El-Sayed, Manal Mohammed Hawash, Mahmoud Abdelwahab Khedr et al. 4 citations

Depression is a prevalent issue among older adults and can significantly impact their overall quality of life. While traditional treatments may not always be sufficient or suitable for all individuals, the potential of alternative interventions, such as mindful walking, offers a ray of hope. This study aimed to evaluate the impact of mindful walking on rumination, agility, vitality, and...

The effects of mindfulness-based techniques on self-rumination, cognitive reappraisal and expressive suppression among patients with major depression: a nursing perspective.

Journal of Research in Nursing August 1, 2024 Mohamed Hussein Ramadan Atta, Ayman Mohamed El-Ashry, Marwa Abd El-Gawad Mousa 23 citations

Patients with major depressive disorder (MDD) often struggle with adaptive strategies like self-reflection and cognitive reappraisal, relying instead on maladaptive ones like self-rumination and emotional suppression. Mindfulness-based techniques (MBTs) have been identified as a promising complementary psychological intervention for this population. To evaluate the effects of MBTs on mindful...

DOI: 10.1177/17449871241252011 (opens in new tab) Full text (opens in new tab) Major depressive disorder Emotional regulation Mindful attention awareness Mindfulness-based techniques +3

Repurposing General Anesthetic Drugs to Treat Depression: A New Frontier for Anesthesiologists in Neuropsychiatric Care.

Anesthesiology August 1, 2024 Connor T A Brenna, Benjamin I Goldstein, Carlos A. Zarate et al. 19 citations

During the last 100 years, the role of anesthesiologists in psychiatry has focused primarily on facilitating electroconvulsive therapy and mitigating postoperative delirium and other perioperative neurocognitive disorders. The discovery of the rapid and sustained antidepressant properties of ketamine, and early results suggesting that other general anesthetic drugs (including nitrous oxide,...

DOI: 10.1097/ALN.0000000000005037 (opens in new tab) Full text (opens in new tab) Depression treatment Anesthetics Mental health Psychiatric medicine +1

Rapid and long-lasting effects of subcutaneous esketamine on suicidality: An open-label study in patients with treatment-resistant depression.

Journal of Psychiatric Research August 1, 2024 Eduardo Igor Torquato Cardoso Lopes, Patrícia Cavalcanti-Ribeiro, Fernanda Palhano-Fontes et al. 9 citations

Therapeutics for suicide management is limited, taking weeks to work. This open-label clinical trial with 18 treatment-resistant depressive patients tested subcutaneous esketamine (8 weekly sessions) for suicidality. We noted a rapid and enduring effect of subcutaneous esketamine, lasting from one week to six months post-treatment, assessed by the Beck Inventory for Suicidality (BSI). There was...